CROs offering Genomics & Sequencing Services with Biologics (Other)
8 published
8 published CROs match Genomics & Sequencing Services and Biologics (Other).
Locations in this set include United States, China, India, Austria, Europe, and France.
Capabilities that show up most often in this set: Bioanalysis, Biomarker Assays, In Vitro Pharmacology, Preclinical In Vitro Studies, and Phase I Clinical Trials.
Matching companies
Champions OncologyLeading oncology CRO specializing in preclinical and clinical specialty testing, with over 1,400 patient-derived xenograft models, comprehensive multi-omic datasets, and proprietary platforms including flow cytometry, NGS, proteomics, and histopathology services.
Crown BiosciencePreclinical oncology CRO offering 2,500+ PDX models, organoid and cell line databases, and translational platforms with biomarker discovery and AI-driven systems biology for drug development.
Custom BiologicsGlobal bioanalytical CRO offering GLP-compliant assay development, validation, and testing for large-molecule biopharmaceuticals. Supports pre-clinical/CMC and clinical stages, including GMP-lot and market release testing.
LabcorpLabcorp is a global life sciences and healthcare company providing diagnostic testing, drug development, nonclinical research, central laboratory services, and real-world data solutions to healthcare providers, health systems, and biopharma companies.
NuvisanFull-service CRO and CDMO with specialized competency centers in drug discovery, formulation development, GMP manufacturing, and bioanalytical services across Germany and France.
PharmaronPremier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.
QPSQPS provides integrated contract research and clinical services spanning bioanalysis, preclinical development, and early-to-late phase clinical trials across multiple therapeutic areas including oncology, dermatology, and women's health.
Syngene InternationalInnovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.
Markdown mirror: /explore/genomics-services/biologics-other.md